Status:
UNKNOWN
Palonosetron and Blood Coagulation
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Blood Coagulation Disorder
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Palonosetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of palonosetron. The investigators therefore will pe...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Age: 20 to 65 years
- Body weight \> 50 kg
- Volunteers who provided informed consent
Exclusion
- Hematologic disease
- Anticoagulant medication
Key Trial Info
Start Date :
September 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04507711
Start Date
September 16 2020
End Date
December 15 2023
Last Update
March 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National Univ. Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707